JPWO2021212097A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021212097A5
JPWO2021212097A5 JP2022563191A JP2022563191A JPWO2021212097A5 JP WO2021212097 A5 JPWO2021212097 A5 JP WO2021212097A5 JP 2022563191 A JP2022563191 A JP 2022563191A JP 2022563191 A JP2022563191 A JP 2022563191A JP WO2021212097 A5 JPWO2021212097 A5 JP WO2021212097A5
Authority
JP
Japan
Prior art keywords
fraction
composition
hyaluronic acid
subject
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022563191A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522079A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/027912 external-priority patent/WO2021212097A1/fr
Publication of JP2023522079A publication Critical patent/JP2023522079A/ja
Publication of JPWO2021212097A5 publication Critical patent/JPWO2021212097A5/ja
Pending legal-status Critical Current

Links

JP2022563191A 2020-04-17 2021-04-19 ヒアルロン酸組成物の制御放出 Pending JP2023522079A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063011996P 2020-04-17 2020-04-17
US63/011,996 2020-04-17
US202163136508P 2021-01-12 2021-01-12
US63/136,508 2021-01-12
PCT/US2021/027912 WO2021212097A1 (fr) 2020-04-17 2021-04-19 Compositions d'acide hyaluronique à libération contrôlée

Publications (2)

Publication Number Publication Date
JP2023522079A JP2023522079A (ja) 2023-05-26
JPWO2021212097A5 true JPWO2021212097A5 (fr) 2024-04-30

Family

ID=78084900

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563191A Pending JP2023522079A (ja) 2020-04-17 2021-04-19 ヒアルロン酸組成物の制御放出

Country Status (4)

Country Link
US (1) US20230172968A1 (fr)
EP (1) EP4135772A4 (fr)
JP (1) JP2023522079A (fr)
WO (1) WO2021212097A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4415771A1 (fr) * 2021-10-15 2024-08-21 Prohibix LLC Précipités d'acide hyaluronique réticulé
WO2023064624A1 (fr) * 2021-10-15 2023-04-20 Prohibix Llc Compositions d'hydrogel gonflantes et stimulant le collagène

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US20060153893A1 (en) * 2002-04-08 2006-07-13 Denki Kagaku Kogyo Kabushiki Kaisha Therapeutic composition for bone infectious disease
US8821928B2 (en) * 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
US8357795B2 (en) * 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US11090387B2 (en) * 2008-12-22 2021-08-17 The Trustees Of The University Of Pennsylvania Hydrolytically degradable polysaccharide hydrogels
EP2459239A1 (fr) * 2009-07-30 2012-06-06 Carbylan Biosurgery, Inc. Compositions de polymère d'acide hyaluronique et procédés associés
FR3006689A1 (fr) * 2013-06-11 2014-12-12 Benedicte Vincente Tauzin Procede de reticulation de l'acide hyaluronique; procede de preparation d'un hydrogel injectable; hydrogel obtenu; utilisation de l'hydroget obtenu
WO2015005345A1 (fr) * 2013-07-08 2015-01-15 電気化学工業株式会社 Particules à noyau-coquille de gel d'acide hyaluronique réticulé, leur procédé de production et matériau médical
KR101459070B1 (ko) * 2013-12-09 2014-11-17 (주) 뉴메딕 지속성을 갖는 히알루론산 겔 조성물
WO2017114867A1 (fr) * 2015-12-29 2017-07-06 Galderma S.A. Réticulateur de glucides
WO2017136427A1 (fr) * 2016-02-02 2017-08-10 The Regents Of The University Of California Hydrogel permettant la sélection de cellule progénitrice neurologique endogène

Similar Documents

Publication Publication Date Title
CN109528695B (zh) 一种治疗类风湿性关节炎的微针透皮给药贴片及其制备方法
JP3094074B2 (ja) 多糖ゲル組成物
KR101224939B1 (ko) 활성 성분의 흡수 속도가 개선된 마이크로니들
KR101400545B1 (ko) 마이크로니들 디바이스 및 그의 제조 방법
JP2003533468A (ja) タンパク質マトリクス物質、製造並びにその製造及び使用
TWI675666B (zh) 溶解特性優秀的透明質酸微結構體
C Patel et al. Recent patents on stimuli responsive hydrogel drug delivery system
JP2007532173A (ja) 軟組織増大用の粒子
JP7345792B2 (ja) マイクロニードルパッチを用いたヒアルロン酸フィラー
JP2007537249A (ja) 荷電ポリマーを含むゲル組成物
JP2010535188A (ja) 関節疾患若しくは関節痛の治療用又は審美的な目的若しくは他の目的のための皮膚の治療用の方法及び化合物並びに化合物の調製方法
CN105209075A (zh) 生物相容性原位水凝胶
CN109621181A (zh) 一种光热响应性复合微针及其制备方法
JP2694372B2 (ja) 微小移植物質
KR20190118155A (ko) 주사용 필러 및 콜라겐 성장을 위한 스캐폴드로 유용한 실리콘 수중유형 조성물
JP2014510590A (ja) フィラー製品および少なくとも1つの生体吸収性および生分解性シリカベースの材料を含む組成物
US20120035531A1 (en) On-demand and reversible drug release by external cue
KR20140133724A (ko) 저분자 메틸셀룰로오스 기반의 비경구 약물 전달 시스템
CN110327488A (zh) 一种注射填充微球制剂及其制备方法
JPWO2021212097A5 (fr)
CN110538166B (zh) 聚乙烯醇缓释膜、聚乙烯醇缓释微针及其制备方法
KR101898816B1 (ko) 저분자 메틸셀룰로오스 기반의 비경구 약물 전달 시스템
KR102460006B1 (ko) 폴리뉴클레오타이드 및 히알루론산 포함하는 피부 필러 조성물의 동결건조 제조방법 및 이에 따라 제조된 폴리뉴클레오타이드 및 히알루론산 포함하는 피부 필러 조성물
JP2022500177A (ja) 微細構造体基盤薬物注入装置およびその製造方法
CN114948852B (zh) 一种用于脑部疾病诊断和治疗的微针系统及其制备方法